Cargando…

MON-196 A Single-Center Experience of Patients with Metastatic Pheochromocytoma/Paraganglioma Treated with (177)Lu-DOTATATE

The prevalence of metastatic pheochromocytoma/paraganglioma (PPGL) is reported to be 3% to 36% of all the cases. The five-year overall survival rate of such patients ranges from 40 to 77%. The management of metastatic PPGL is challenging taking into account the fact that the optimal strategies for c...

Descripción completa

Detalles Bibliográficos
Autores principales: Roslyakova, Anna, Beltsevich, Dmitry, Plotkin, Michail, Rumyantsev, Pavel, Ladygina, Daria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209615/
http://dx.doi.org/10.1210/jendso/bvaa046.1812